Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last session and the average volume of the stock remained 815.19K … Continue reading Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)